Blocknomi
Key Highlights FDA has granted priority review designation to two supplemental Biologics License Applications for KEYTRUDA and KEYTRUDA QLEX when used alongside Padcev. These submissions focus on treating muscle-invasive bladder…
Related articles
-
Top Crypto Presale for April 2026: IPO Genie Targets 50x Gains As Phase 82 Nears Completion
BlockchainReporter Published 14.04.2026 10:10
-
Whales Circle AAVE Amid Chaos: Is This Another Market Bottom Signal?
CryptoPotato Published 21.04.2026 12:49
-
Best Crypto to Buy in 2026: BlockDAG, XRP, TRON, & Avalanche Lead the Market
Blocknomi Published 21.04.2026 17:00
-
Stablecoins Don’t Meet Core Requirements Of Money, BIS Says
Bitcoinist Published 20.04.2026 21:00
-
Hyperliquid (HYPE) ETF Inches Closer as Bitwise Files Key Amendment and Hayes Adds to Position
Blocknomi Published 12.04.2026 08:08
-
21+ Best AAVE Crypto Casinos & Gambling Sites: Our Top Picks Ranked
Blocknomi Published 20.04.2026 09:07
-
Fake Ledger Wallet Exposed With Hidden Chip Stealing Seed Phrases and PINs
CryptoPotato Published 18.04.2026 03:45
-
Top 10 Crypto Sportsbooks German Bettors Use — Bonuses, Coins, and Risks Compared
Crypto Daily Published 18.04.2026 18:48